AdvanSix (NYSE:ASIX – Free Report) had its price objective raised by Piper Sandler from $35.00 to $39.00 in a research report released on Friday,Benzinga reports. The brokerage currently has an overweight rating on the stock.
Separately, StockNews.com raised shares of AdvanSix from a “hold” rating to a “buy” rating in a report on Monday, August 5th.
Read Our Latest Research Report on AdvanSix
AdvanSix Stock Up 0.1 %
AdvanSix Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th will be given a $0.16 dividend. The ex-dividend date is Tuesday, November 12th. This represents a $0.64 annualized dividend and a dividend yield of 2.06%. AdvanSix’s dividend payout ratio is 45.39%.
Insiders Place Their Bets
In other news, CEO Erin N. Kane sold 5,000 shares of the company’s stock in a transaction dated Friday, November 1st. The shares were sold at an average price of $30.37, for a total transaction of $151,850.00. Following the completion of the transaction, the chief executive officer now owns 517,795 shares of the company’s stock, valued at approximately $15,725,434.15. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other AdvanSix news, insider Christopher Gramm sold 2,435 shares of AdvanSix stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $32.00, for a total transaction of $77,920.00. Following the sale, the insider now owns 43,463 shares in the company, valued at $1,390,816. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Erin N. Kane sold 5,000 shares of the company’s stock in a transaction dated Friday, November 1st. The shares were sold at an average price of $30.37, for a total transaction of $151,850.00. Following the completion of the sale, the chief executive officer now directly owns 517,795 shares in the company, valued at approximately $15,725,434.15. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 13,418 shares of company stock worth $411,626 in the last ninety days. Insiders own 5.60% of the company’s stock.
Hedge Funds Weigh In On AdvanSix
A number of hedge funds have recently modified their holdings of ASIX. SummerHaven Investment Management LLC boosted its stake in shares of AdvanSix by 3.4% in the 2nd quarter. SummerHaven Investment Management LLC now owns 20,404 shares of the company’s stock valued at $468,000 after purchasing an additional 672 shares in the last quarter. Meritage Portfolio Management boosted its position in AdvanSix by 9.1% in the third quarter. Meritage Portfolio Management now owns 10,429 shares of the company’s stock valued at $317,000 after buying an additional 871 shares in the last quarter. Copeland Capital Management LLC bought a new stake in AdvanSix during the third quarter worth about $41,000. Point72 DIFC Ltd acquired a new stake in shares of AdvanSix during the second quarter worth approximately $34,000. Finally, Acadian Asset Management LLC bought a new position in shares of AdvanSix in the second quarter valued at approximately $36,000. 86.39% of the stock is owned by institutional investors and hedge funds.
AdvanSix Company Profile
AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.
Featured Stories
- Five stocks we like better than AdvanSix
- Want to Profit on the Downtrend? Downtrends, Explained.
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- The 3 Best Retail Stocks to Shop for in August
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.